Literature DB >> 33399431

Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Children in a Large Regional US Health System During the Coronavirus Disease 2019 Pandemic.

David R Peaper1, Christina Murdzek2, Carlos R Oliveira3,4, Thomas S Murray2,3.   

Abstract

BACKGROUND: The objective was to evaluate patterns of pediatric coronavirus disease 2019 testing in a large health system throughout the pandemic, before and after school reopening.
METHODS: This was a cross-sectional time-series study of clinical virology results from children tested for severe acute respiratory syndrome coronavirus 2 in Southern Connecticut and areas of New York and Rhode Island. Data collected include demographics, hospital admission, changes in percent positive tests over time, detection intervals in persistently positive children and cycle threshold values. The setting was the Yale New Haven Health System has 6 hospitals at 4 Connecticut locations, 1 hospital in Rhode Island and ambulatory locations in Connecticut, Rhode Island and New York. Participants included twenty-three-thousand one-hundred thirty-seven children ≤ 18 years of age, tested for coronavirus disease 2019 at an ambulatory testing site, the emergency department or on an inpatient unit within the Yale New Haven Health System.
RESULTS: Among all tests, 3.2% were positive. Older children consistently made up the larger portion of positive pediatric cases, regardless of community prevalence. Increased pediatric cases later in the pandemic when prevalence in adults was relatively low correlates with a higher number of tests performed in children and not with an increased positivity rate. No significant changes in trends of positivity were detected after the reopening of schools. Symptomatic and asymptomatic children had similar cycle threshold values regardless of age, and a subset of children demonstrated persistent viral detection, some for as long as 6 weeks.
CONCLUSION: An increase in pediatric cases documented in the late summer was predominately due to increased access to testing for children. The percent positivity in children did not change in the first 3 weeks after school opened. A subset of children has detectable severe acute respiratory syndrome coronavirus 2 RNA in the upper respiratory tract for weeks after the initial infection.
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33399431      PMCID: PMC8852689          DOI: 10.1097/INF.0000000000003024

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  18 in total

1.  Duration of Respiratory and Gastrointestinal Viral Shedding in Children With SARS-CoV-2: A Systematic Review and Synthesis of Data.

Authors:  Cecilia L H Xu; Manjri Raval; Jesse A Schnall; Jason C Kwong; Natasha E Holmes
Journal:  Pediatr Infect Dis J       Date:  2020-09       Impact factor: 2.129

2.  Symptomatic and Asymptomatic Viral Shedding in Pediatric Patients Infected With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Under the Surface.

Authors:  Roberta L DeBiasi; Meghan Delaney
Journal:  JAMA Pediatr       Date:  2021-01-01       Impact factor: 16.193

3.  Epidemiology of COVID-19 Among Children in China.

Authors:  Yuanyuan Dong; Xi Mo; Yabin Hu; Xin Qi; Fan Jiang; Zhongyi Jiang; Shilu Tong
Journal:  Pediatrics       Date:  2020-03-16       Impact factor: 7.124

4.  COVID-19 Transmission in US Child Care Programs.

Authors:  Walter S Gilliam; Amyn A Malik; Mehr Shafiq; Madeline Klotz; Chin Reyes; John Eric Humphries; Thomas Murray; Jad A Elharake; David Wilkinson; Saad B Omer
Journal:  Pediatrics       Date:  2020-10-14       Impact factor: 7.124

5.  SARS-CoV-2 in children and adolescents in Norway: confirmed infection, hospitalisations and underlying conditions.

Authors:  Ketil Størdal; Inger Johanne Bakken; Margrethe Greve-Isdahl; Claus Klingenberg; Eyvind Helland; Wenche Nystad; Vidar Hjellvik; Hanne Løvdal Gulseth
Journal:  Tidsskr Nor Laegeforen       Date:  2020-06-24

6.  Multisystem Inflammatory Syndrome in U.S. Children and Adolescents.

Authors:  Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph
Journal:  N Engl J Med       Date:  2020-06-29       Impact factor: 91.245

7.  Pandemic school closures: risks and opportunities.

Authors: 
Journal:  Lancet Child Adolesc Health       Date:  2020-04-08

8.  Challenges in use of saliva for detection of SARS CoV-2 RNA in symptomatic outpatients.

Authors:  Marie L Landry; Jody Criscuolo; David R Peaper
Journal:  J Clin Virol       Date:  2020-07-31       Impact factor: 3.168

9.  COVID-19 in children: analysis of the first pandemic peak in England.

Authors:  Shamez N Ladhani; Zahin Amin-Chowdhury; Hannah G Davies; Felicity Aiano; Iain Hayden; Joanne Lacy; Mary Sinnathamby; Simon de Lusignan; Alicia Demirjian; Heather Whittaker; Nick Andrews; Maria Zambon; Susan Hopkins; Mary Elizabeth Ramsay
Journal:  Arch Dis Child       Date:  2020-08-12       Impact factor: 3.791

10.  Epidemiology and transmission dynamics of COVID-19 in two Indian states.

Authors:  Ramanan Laxminarayan; Brian Wahl; Shankar Reddy Dudala; K Gopal; Chandra Mohan B; S Neelima; K S Jawahar Reddy; J Radhakrishnan; Joseph A Lewnard
Journal:  Science       Date:  2020-09-30       Impact factor: 47.728

View more
  3 in total

Review 1.  The clinical epidemiology of coronavirus disease 2019 in children and adolescents mirrors the widening gap in healthcare disparities.

Authors:  Elissa Zirinsky; Elijah Paintsil; Carlos R Oliveira
Journal:  Curr Opin Pediatr       Date:  2021-06-01       Impact factor: 2.893

2.  COVID-19 in children and young adults with kidney disease: risk factors, clinical features and serological response.

Authors:  Jenny Weinbrand-Goichberg; Efrat Ben Shalom; Choni Rinat; Sapir Choshen; Shimrit Tzvi-Behr; Yaacov Frishberg; Rachel Becker-Cohen
Journal:  J Nephrol       Date:  2021-10-15       Impact factor: 4.393

3.  Clinical features and characteristics of pediatric patients with COVID-19 infection: Experiences in a Tertiary Taiwan Hospital.

Authors:  Geng-Hao Bai; Ping-Yi Shih; Shih-Yen Chen; Kai-Sheng Hsieh; Cheng-Che Chou; Po-Hao Feng; Shu-Sing Kong; Wen-Chuan Lin; Meng-Che Lu
Journal:  Medicine (Baltimore)       Date:  2022-09-02       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.